Although the mechanisms of BTZ function in liver fibrosis remain incompletely understood, it exerts its antifibrotic action mainly by inhibiting the NF-κB pathway components associated with TGF-β1 during the inducing apoptotic process. Here, TGFB1 is linked to Hepatic fibrosis.